Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,...
Reports $17.3 million in net sales, $2.9 million in gross profit, and 17% gross margin in the first quarter 2026. Announces operational changes that are...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,...
Net sales for the fourth quarter and full-year 2025 were $18.3 million and $69.3 million, respectively. Achieved profitability on an Adjusted EBITDA basis...
Net sales for the fourth quarter and full-year 2025 were $18.3 million and $69.3 million, respectively. Achieved profitability on an Adjusted EBITDA basis...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide,...